Vaccination against viral hepatitis B in patients undergoing liver transplantation for hepatitis B-unassociated causes
To study efficiency of molgramostim as an adjuvant in HBV vaccination we randomized 18 pts after OLT due to non-HBV causes. Nine pts received GM-CSF (150 mcg of sc 24 h before 1st dose of vaccine). Other 9 pts received only vaccine. Both groups of pts did not differ in sex, age, immunosuppression an...
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department
2018-08-01
|
| Saila: | Трансплантология (Москва) |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.jtransplantologiya.ru/jour/article/view/289 |